Analysis of the US FDA adverse event reporting system to identify adverse cardiac events associated with hydroxychloroquine in older adults

Research output: Contribution to journalArticle

Original languageEnglish
JournalPharmacoepidemiology and Drug Safety
Early online date19 Oct 2020
DOIs
Publication statusE-pub ahead of print - 19 Oct 2020

Cite this